RNAC
Cartesian Therapeutics Inc.
7.60$
-3.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -140.7% | -281.7% | -272.6% | -43.2% | 3,537.7% | – | -2,100.7% | -5,879.5% | -3,451.3% | -1,870.3% | -28,378.2% | – | -5,150.5% | |
| 2.9% | 3.3% | 3.1% | 0.6% | 77.5% | – | 105.1% | 197.7% | 134.1% | 64.2% | 788.5% | – | 176.6% | |
| 35.4% | 210.5% | 24.5% | 4.8% | 438.0% | – | 228.0% | 1,100.3% | 573.0% | 226.4% | 3,106.4% | – | 625.6% | |
| -0.5% | -53.7% | -109.1% | -95.9% | 6,669.0% | – | -643.8% | -506.0% | 117.3% | -0.3% | 87.2% | – | 66.6% | |
| 0.0% | 0.8% | 10.3% | 4.7% | 1,601.8% | – | 97.7% | 870.8% | 285.8% | 52.0% | 34.6% | – | 141.0% | |
| – | 78.6% | -10.3% | -4.7% | -1,601.8% | – | -97.7% | -870.8% | -285.8% | -52.0% | -34.6% | – | -141.0% | |
| – | – | – | – | 0.0% | – | – | – | – | – | – | – | – | |
| -378.4% | 170.3% | 736.8% | 0.4% | 32,169.0% | – | -729.5% | 20.1% | -8.4% | -5.5% | 20,091.0% | – | 3,402.4% | |
| -519.4% | -32.6% | 453.9% | -47.5% | 34,101.0% | – | -2,925.1% | -6,726.2% | -3,747.8% | -1,926.6% | -8,330.8% | – | -1,891.2% | |
| -140.7% | -282.5% | -282.9% | -47.9% | 1,935.9% | – | -2,198.5% | -6,750.3% | -3,737.2% | -1,922.3% | -28,412.8% | – | -5,291.5% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.